Abstract
Resistance to immune checkpoint inhibitors (ICIs) is a major issue of the current era in cancer immunotherapy. Immune evasion is a multi-factorial eve......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
